Cite

HARVARD Citation

    Selinger, C. et al. (n.d.). P.11.2: The Impact of Infliximab Therapeutic Drug Monitoring on Decisions Made in a Virtual Biologics Clinic for Inflammatory Bowel Disease. Digestive and liver disease. pp. e202-. [Online]. 
  
Back to record